280 related articles for article (PubMed ID: 7981076)
1. Alteration of p53 gene in ovarian carcinoma: clinicopathological correlation and prognostic significance.
Niwa K; Itoh M; Murase T; Morishita S; Itoh N; Mori H; Tamaya T
Br J Cancer; 1994 Dec; 70(6):1191-7. PubMed ID: 7981076
[TBL] [Abstract][Full Text] [Related]
2. Alteration of the p53 tumor suppressor gene occurs independently of K-ras activation and more frequently in serous adenocarcinomas than in other common epithelial tumors of the human ovary.
Fujita M; Enomoto T; Inoue M; Tanizawa O; Ozaki M; Rice JM; Nomura T
Jpn J Cancer Res; 1994 Dec; 85(12):1247-56. PubMed ID: 7852189
[TBL] [Abstract][Full Text] [Related]
3. Expression and mutation of p53 in tumor effusion cells of patients with ovarian carcinoma: response to cisplatin-based chemotherapy.
Bar JK; Harłozińska A; Popiela A; Noga L
Tumour Biol; 2001; 22(2):83-91. PubMed ID: 11125280
[TBL] [Abstract][Full Text] [Related]
4. p53 mutation is infrequent in clear cell carcinoma of the ovary.
Ho ES; Lai CR; Hsieh YT; Chen JT; Lin AJ; Hung MH; Liu FS
Gynecol Oncol; 2001 Feb; 80(2):189-93. PubMed ID: 11161858
[TBL] [Abstract][Full Text] [Related]
5. TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type.
Rechsteiner M; Zimmermann AK; Wild PJ; Caduff R; von Teichman A; Fink D; Moch H; Noske A
Exp Mol Pathol; 2013 Oct; 95(2):235-41. PubMed ID: 23965232
[TBL] [Abstract][Full Text] [Related]
6. p53 expression, mutation, and allelic deletion in ovarian cancer.
McManus DT; Yap EP; Maxwell P; Russell SE; Toner PG; McGee JO
J Pathol; 1994 Nov; 174(3):159-68. PubMed ID: 7823248
[TBL] [Abstract][Full Text] [Related]
7. Frequent mutations of p53 gene in oesophageal squamous cell carcinomas with and without human papillomavirus (HPV) involvement suggest the dominant role of environmental carcinogens in oesophageal carcinogenesis.
Chang F; Syrjänen S; Tervahauta A; Kurvinen K; Wang L; Syrjänen K
Br J Cancer; 1994 Aug; 70(2):346-51. PubMed ID: 8054284
[TBL] [Abstract][Full Text] [Related]
8. Aberrations of the p53 tumor suppressor gene in human epithelial ovarian carcinoma.
Kim JW; Cho YH; Kwon DJ; Kim TE; Park TC; Lee JM; Namkoong SE
Gynecol Oncol; 1995 May; 57(2):199-204. PubMed ID: 7729734
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity in P53, BRCA1, and estrogen receptor genes and correlation to expression of p53 protein in ovarian epithelial tumors of different cell types and biological behavior.
Otis CN; Krebs PA; Quezado MM; Albuquerque A; Bryant B; San Juan X; Kleiner D; Sobel ME; Merino MJ
Hum Pathol; 2000 Feb; 31(2):233-8. PubMed ID: 10685639
[TBL] [Abstract][Full Text] [Related]
10. p53 mutation in epithelial ovarian carcinoma and borderline ovarian tumor.
Lee JH; Kang YS; Park SY; Kim BG; Lee ED; Lee KH; Park KB; Kavanagh JJ; Wharton JT
Cancer Genet Cytogenet; 1995 Nov; 85(1):43-50. PubMed ID: 8536236
[TBL] [Abstract][Full Text] [Related]
11. [Alterations of p53 gene in human ovarian tumor].
Chen P; Zhang Z; Zhang Q; Wu Y
Hunan Yi Ke Da Xue Xue Bao; 1997; 22(5):401-3. PubMed ID: 10073019
[TBL] [Abstract][Full Text] [Related]
12. p53 gene mutations and codon 72 polymorphism in ovarian carcinoma patients from Serbia.
Malisic E; Jankovic R; Slavkovic D; Milovic-Kovacevic M; Radulovic S
J BUON; 2010; 15(1):101-6. PubMed ID: 20414935
[TBL] [Abstract][Full Text] [Related]
13. Exon 8-9 mutations of DNA polymerase β in ovarian carcinoma patients from Haldia, India.
Khanra K; Panda K; Mitra AK; Sarkar R; Bhattacharya C; Bhattacharya N
Asian Pac J Cancer Prev; 2012; 13(8):4183-6. PubMed ID: 23098424
[TBL] [Abstract][Full Text] [Related]
14. Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells.
Hietanen SH; Kurvinen K; Syrjänen K; Grénman S; Carey T; McClatchey K; Syrjänen S
Am J Obstet Gynecol; 1995 Nov; 173(5):1477-82. PubMed ID: 7503188
[TBL] [Abstract][Full Text] [Related]
15. PPP2R1A mutation is a rare event in ovarian carcinoma across histological subtypes.
Rahman M; Nakayama K; Rahman MT; Nakayama N; Katagiri H; Katagiri A; Ishibashi T; Ishikawa M; Iida K; Otsuki Y; Nakayama S; Miyazaki K
Anticancer Res; 2013 Jan; 33(1):113-8. PubMed ID: 23267135
[TBL] [Abstract][Full Text] [Related]
16. Geographical variations in TP53 mutational spectrum in ovarian carcinomas.
Dansonka-Mieszkowska A; Ludwig AH; Kraszewska E; Kupryjańczyk J
Ann Hum Genet; 2006 Sep; 70(Pt 5):594-604. PubMed ID: 16907706
[TBL] [Abstract][Full Text] [Related]
17. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
Huang C; Taki T; Adachi M; Konishi T; Higashiyama M; Miyake M
Oncogene; 1998 May; 16(19):2469-77. PubMed ID: 9627113
[TBL] [Abstract][Full Text] [Related]
18. [Detection and sequence analysis of the p53 gene mutation in epithelial ovarian cancer].
Guan X; Lang J; Bian M
Zhonghua Fu Chan Ke Za Zhi; 1998 Mar; 33(3):165-7. PubMed ID: 10682487
[TBL] [Abstract][Full Text] [Related]
19. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
[TBL] [Abstract][Full Text] [Related]
20. Mutation of the p53 gene precedes aneuploid clonal divergence in colorectal carcinoma.
Carder PJ; Cripps KJ; Morris R; Collins S; White S; Bird CC; Wyllie AH
Br J Cancer; 1995 Feb; 71(2):215-8. PubMed ID: 7841032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]